
Pfizer (PFE) stock has fallen quite a long way since peaking back in December 2021 at over $59 per share. The COVID-19 vaccine boom helped propel shares to highs not seen in decades.
Fast forward to today, and the stock is fresh off a vicious 46% implosion from those highs. It's hard to believe, but shares are right back to where they were back in 2020, well before Pfizer unveiled its mRNA vaccine to combat the COVID-19 pandemic.